Percutaneous Endoscopic Tracheal Plug/Unplug for CDH (Congenital Diaphragmatic Hernia)
Primary Purpose
Severe Congenital Diaphragmatic Hernia
Status
No longer available
Phase
Locations
United States
Study Type
Expanded Access
Intervention
Percutaneous endoscopic fetal tracheal occlusion/unocclusion
Sponsored by
About this trial
This is an expanded access trial for Severe Congenital Diaphragmatic Hernia focused on measuring Congenital diaphragmatic hernia, lung-head ratio, percutaneous tracheal occlusion, fetal intervention
Eligibility Criteria
General subject population: Pregnant women in the second trimester, at least 18 years of age, and of any and all ethnic backgrounds.
Inclusion Criteria:
- Confirmed diagnosis of CDH
- Normal fetal echocardiogram
- Normal karyotype
- Fetal liver herniated into the left hemithorax
- Lung-head ratio (LHR) is 1.0 or less, calculated between 24-26 weeks' gestation
- Fetus is between 26 and 28 weeks' gestation
- Singleton pregnancy
- Mother meets psychosocial criteria
- Pre-authorization from third-party payor for fetal intervention, or ability to self-pay.
Exclusion Criteria:
- Failure to meet all inclusion criteria
- Other congenital anomalies detected on ultrasound
- Contraindication to abdominal surgery or general anesthesia
- Allergy to latex
- Preterm labor, preeclampsia, or uterine anomaly (e.g., large fibroid tumor)
- Family unable or refuses to stay in San Francisco for duration of the tracheal occlusion period and for the duration of the pregnancy as medically necessary.
Sites / Locations
- University of California, San Francisco Fetal Treatment Center
Outcomes
Primary Outcome Measures
Secondary Outcome Measures
Full Information
NCT ID
NCT00768703
First Posted
October 6, 2008
Last Updated
March 25, 2019
Sponsor
University of California, San Francisco
1. Study Identification
Unique Protocol Identification Number
NCT00768703
Brief Title
Percutaneous Endoscopic Tracheal Plug/Unplug for CDH (Congenital Diaphragmatic Hernia)
Official Title
Percutaneous Endoscopic Tracheal Plug/Unplug for Congenital Diaphragmatic Hernia
Study Type
Expanded Access
2. Study Status
Record Verification Date
March 2019
Overall Recruitment Status
No longer available
Study Start Date
undefined (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of California, San Francisco
4. Oversight
5. Study Description
Brief Summary
Congenital diaphragmatic hernia is an anatomically simple birth defect in which contents of the fetal abdomen migrate into the chest due to incomplete formation of the diaphragm. Herniation of viscera into the chest prevents the fetal lungs from developing and growing to normal size. In the most severe cases, there is significant morbidity and mortality at birth. For these fetuses, fetal intervention may improve outcomes by enabling the lungs to grow enough in utero that they are capable of sustaining life after birth. This unblinded, non-randomized trial will assess the safety and efficacy of the use of the Goldvalve balloon and MiniTorquer microcatheter to perform percutaneous temporary tracheal occlusion to treat severe CDH in utero. The primary outcome variable will be fetal lung growth due to successful 'plugging/unplugging' of the trachea, as determined by serial lung-head ratio (LHR) measurements. Secondary outcome variables include maternal, fetal and neonatal variables, specifically neonatal survival at 90 days of life. For infants who survive beyond 90 days post-delivery, their families will be offered follow-up (up to 2 years of age and possibly beyond) in the Long-term Infant-to-Adult Follow-up Evaluation (LIFE) Clinic at UCSF.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Severe Congenital Diaphragmatic Hernia
Keywords
Congenital diaphragmatic hernia, lung-head ratio, percutaneous tracheal occlusion, fetal intervention
7. Study Design
8. Arms, Groups, and Interventions
Intervention Type
Device
Intervention Name(s)
Percutaneous endoscopic fetal tracheal occlusion/unocclusion
Other Intervention Name(s)
Goldvalve Balloon and MiniTorquer Delivery Microcatheter
Intervention Description
Between 26-28 wks' gestation, percutaneous endoscopic placement of the tracheal balloon. Between 32-34 wks' gestation, percutaneous endoscopic removal of the balloon.
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
General subject population: Pregnant women in the second trimester, at least 18 years of age, and of any and all ethnic backgrounds.
Inclusion Criteria:
Confirmed diagnosis of CDH
Normal fetal echocardiogram
Normal karyotype
Fetal liver herniated into the left hemithorax
Lung-head ratio (LHR) is 1.0 or less, calculated between 24-26 weeks' gestation
Fetus is between 26 and 28 weeks' gestation
Singleton pregnancy
Mother meets psychosocial criteria
Pre-authorization from third-party payor for fetal intervention, or ability to self-pay.
Exclusion Criteria:
Failure to meet all inclusion criteria
Other congenital anomalies detected on ultrasound
Contraindication to abdominal surgery or general anesthesia
Allergy to latex
Preterm labor, preeclampsia, or uterine anomaly (e.g., large fibroid tumor)
Family unable or refuses to stay in San Francisco for duration of the tracheal occlusion period and for the duration of the pregnancy as medically necessary.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Hanmin Lee, MD
Organizational Affiliation
University of California, San Francisco Fetal Treatment Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of California, San Francisco Fetal Treatment Center
City
San Francisco
State/Province
California
ZIP/Postal Code
94143
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
16769018
Citation
Jani JC, Nicolaides KH, Gratacos E, Vandecruys H, Deprest JA; FETO Task Group. Fetal lung-to-head ratio in the prediction of survival in severe left-sided diaphragmatic hernia treated by fetal endoscopic tracheal occlusion (FETO). Am J Obstet Gynecol. 2006 Dec;195(6):1646-50. doi: 10.1016/j.ajog.2006.04.004. Epub 2006 Jun 12.
Results Reference
background
PubMed Identifier
18634116
Citation
Done E, Gucciardo L, Van Mieghem T, Jani J, Cannie M, Van Schoubroeck D, Devlieger R, Catte LD, Klaritsch P, Mayer S, Beck V, Debeer A, Gratacos E, Nicolaides K, Deprest J. Prenatal diagnosis, prediction of outcome and in utero therapy of isolated congenital diaphragmatic hernia. Prenat Diagn. 2008 Jul;28(7):581-91. doi: 10.1002/pd.2033.
Results Reference
background
PubMed Identifier
15868556
Citation
Cortes RA, Keller RL, Townsend T, Harrison MR, Farmer DL, Lee H, Piecuch RE, Leonard CH, Hetherton M, Bisgaard R, Nobuhara KK. Survival of severe congenital diaphragmatic hernia has morbid consequences. J Pediatr Surg. 2005 Jan;40(1):36-45; discussion 45-6. doi: 10.1016/j.jpedsurg.2004.09.037.
Results Reference
background
PubMed Identifier
15319458
Citation
Keller RL, Hawgood S, Neuhaus JM, Farmer DL, Lee H, Albanese CT, Harrison MR, Kitterman JA. Infant pulmonary function in a randomized trial of fetal tracheal occlusion for severe congenital diaphragmatic hernia. Pediatr Res. 2004 Nov;56(5):818-25. doi: 10.1203/01.PDR.0000141518.19721.D7. Epub 2004 Aug 19.
Results Reference
background
PubMed Identifier
14614166
Citation
Harrison MR, Keller RL, Hawgood SB, Kitterman JA, Sandberg PL, Farmer DL, Lee H, Filly RA, Farrell JA, Albanese CT. A randomized trial of fetal endoscopic tracheal occlusion for severe fetal congenital diaphragmatic hernia. N Engl J Med. 2003 Nov 13;349(20):1916-24. doi: 10.1056/NEJMoa035005.
Results Reference
background
PubMed Identifier
11568805
Citation
Harrison MR, Albanese CT, Hawgood SB, Farmer DL, Farrell JA, Sandberg PL, Filly RA. Fetoscopic temporary tracheal occlusion by means of detachable balloon for congenital diaphragmatic hernia. Am J Obstet Gynecol. 2001 Sep;185(3):730-3. doi: 10.1067/mob.2001.117344.
Results Reference
background
PubMed Identifier
25102346
Citation
Ruano R, Ali RA, Patel P, Cass D, Olutoye O, Belfort MA. Fetal endoscopic tracheal occlusion for congenital diaphragmatic hernia: indications, outcomes, and future directions. Obstet Gynecol Surv. 2014 Mar;69(3):147-58. doi: 10.1097/OGX.0000000000000045.
Results Reference
background
PubMed Identifier
23444265
Citation
Done E, Gratacos E, Nicolaides KH, Allegaert K, Valencia C, Castanon M, Martinez JM, Jani J, Van Mieghem T, Greenough A, Gomez O, Lewi P, Deprest J. Predictors of neonatal morbidity in fetuses with severe isolated congenital diaphragmatic hernia undergoing fetoscopic tracheal occlusion. Ultrasound Obstet Gynecol. 2013 Jul;42(1):77-83. doi: 10.1002/uog.12445.
Results Reference
background
Links:
URL
http://fetus.ucsfmedicalcenter.org/
Description
UCSF Fetal Treatment Center
Learn more about this trial
Percutaneous Endoscopic Tracheal Plug/Unplug for CDH (Congenital Diaphragmatic Hernia)
We'll reach out to this number within 24 hrs